The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myeloid Cells Targeting Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Intravenous Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Myeloid Cells Targeting Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oncological Disorders
1.3.3 Rare Disorders
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Myeloid Cells Targeting Therapeutics Market Perspective (2017-2028)
2.2 Myeloid Cells Targeting Therapeutics Growth Trends by Region
2.2.1 Myeloid Cells Targeting Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Myeloid Cells Targeting Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Myeloid Cells Targeting Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Myeloid Cells Targeting Therapeutics Market Dynamics
2.3.1 Myeloid Cells Targeting Therapeutics Industry Trends
2.3.2 Myeloid Cells Targeting Therapeutics Market Drivers
2.3.3 Myeloid Cells Targeting Therapeutics Market Challenges
2.3.4 Myeloid Cells Targeting Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myeloid Cells Targeting Therapeutics Players by Revenue
3.1.1 Global Top Myeloid Cells Targeting Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Myeloid Cells Targeting Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Myeloid Cells Targeting Therapeutics Revenue
3.4 Global Myeloid Cells Targeting Therapeutics Market Concentration Ratio
3.4.1 Global Myeloid Cells Targeting Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myeloid Cells Targeting Therapeutics Revenue in 2021
3.5 Myeloid Cells Targeting Therapeutics Key Players Head office and Area Served
3.6 Key Players Myeloid Cells Targeting Therapeutics Product Solution and Service
3.7 Date of Enter into Myeloid Cells Targeting Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Myeloid Cells Targeting Therapeutics Breakdown Data by Type
4.1 Global Myeloid Cells Targeting Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Type (2023-2028)
5 Myeloid Cells Targeting Therapeutics Breakdown Data by Application
5.1 Global Myeloid Cells Targeting Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Myeloid Cells Targeting Therapeutics Market Size (2017-2028)
6.2 North America Myeloid Cells Targeting Therapeutics Market Size by Country (2017-2022)
6.3 North America Myeloid Cells Targeting Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Myeloid Cells Targeting Therapeutics Market Size (2017-2028)
7.2 Europe Myeloid Cells Targeting Therapeutics Market Size by Country (2017-2022)
7.3 Europe Myeloid Cells Targeting Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Myeloid Cells Targeting Therapeutics Market Size (2017-2028)
9.2 Latin America Myeloid Cells Targeting Therapeutics Market Size by Country (2017-2022)
9.3 Latin America Myeloid Cells Targeting Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 ChemoCentryx
11.1.1 ChemoCentryx Company Detail
11.1.2 ChemoCentryx Business Overview
11.1.3 ChemoCentryx Myeloid Cells Targeting Therapeutics Introduction
11.1.4 ChemoCentryx Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.1.5 ChemoCentryx Recent Development
11.2 Daiichi Sankyo
11.2.1 Daiichi Sankyo Company Detail
11.2.2 Daiichi Sankyo Business Overview
11.2.3 Daiichi Sankyo Myeloid Cells Targeting Therapeutics Introduction
11.2.4 Daiichi Sankyo Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.2.5 Daiichi Sankyo Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Myeloid Cells Targeting Therapeutics Introduction
11.3.4 Gilead Sciences Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.3.5 Gilead Sciences Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Detail
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Myeloid Cells Targeting Therapeutics Introduction
11.4.4 Janssen Biotech Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.4.5 Janssen Biotech Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Myeloid Cells Targeting Therapeutics Introduction
11.5.4 Roche Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.5.5 Roche Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Myeloid Cells Targeting Therapeutics Introduction
11.6.4 Pfizer Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.6.5 Pfizer Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Myeloid Cells Targeting Therapeutics Introduction
11.7.4 GlaxoSmithKline Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.7.5 GlaxoSmithKline Recent Development
11.8 Macrophage Pharma
11.8.1 Macrophage Pharma Company Detail
11.8.2 Macrophage Pharma Business Overview
11.8.3 Macrophage Pharma Myeloid Cells Targeting Therapeutics Introduction
11.8.4 Macrophage Pharma Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.8.5 Macrophage Pharma Recent Development
11.9 Enlivex
11.9.1 Enlivex Company Detail
11.9.2 Enlivex Business Overview
11.9.3 Enlivex Myeloid Cells Targeting Therapeutics Introduction
11.9.4 Enlivex Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.9.5 Enlivex Recent Development
11.10 Immune-Onc Therapeutics
11.10.1 Immune-Onc Therapeutics Company Detail
11.10.2 Immune-Onc Therapeutics Business Overview
11.10.3 Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Introduction
11.10.4 Immune-Onc Therapeutics Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.10.5 Immune-Onc Therapeutics Recent Development
11.11 Infinity Pharmaceuticals
11.11.1 Infinity Pharmaceuticals Company Detail
11.11.2 Infinity Pharmaceuticals Business Overview
11.11.3 Infinity Pharmaceuticals Myeloid Cells Targeting Therapeutics Introduction
11.11.4 Infinity Pharmaceuticals Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.11.5 Infinity Pharmaceuticals Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Detail
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Myeloid Cells Targeting Therapeutics Introduction
11.12.4 AstraZeneca Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022)
11.12.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Myeloid Cells Targeting Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Oral
Table 4. Global Myeloid Cells Targeting Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Myeloid Cells Targeting Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Myeloid Cells Targeting Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Myeloid Cells Targeting Therapeutics Market Share by Region (2017-2022)
Table 8. Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Myeloid Cells Targeting Therapeutics Market Share by Region (2023-2028)
Table 10. Myeloid Cells Targeting Therapeutics Market Trends
Table 11. Myeloid Cells Targeting Therapeutics Market Drivers
Table 12. Myeloid Cells Targeting Therapeutics Market Challenges
Table 13. Myeloid Cells Targeting Therapeutics Market Restraints
Table 14. Global Myeloid Cells Targeting Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Myeloid Cells Targeting Therapeutics Market Share by Players (2017-2022)
Table 16. Global Top Myeloid Cells Targeting Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myeloid Cells Targeting Therapeutics as of 2021)
Table 17. Ranking of Global Top Myeloid Cells Targeting Therapeutics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Myeloid Cells Targeting Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Myeloid Cells Targeting Therapeutics Product Solution and Service
Table 21. Date of Enter into Myeloid Cells Targeting Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Myeloid Cells Targeting Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Type (2017-2022)
Table 25. Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Type (2023-2028)
Table 27. Global Myeloid Cells Targeting Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Application (2017-2022)
Table 29. Global Myeloid Cells Targeting Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Myeloid Cells Targeting Therapeutics Revenue Market Share by Application (2023-2028)
Table 31. North America Myeloid Cells Targeting Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Myeloid Cells Targeting Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Myeloid Cells Targeting Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Myeloid Cells Targeting Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Myeloid Cells Targeting Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Myeloid Cells Targeting Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 41. ChemoCentryx Company Detail
Table 42. ChemoCentryx Business Overview
Table 43. ChemoCentryx Myeloid Cells Targeting Therapeutics Product
Table 44. ChemoCentryx Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 45. ChemoCentryx Recent Development
Table 46. Daiichi Sankyo Company Detail
Table 47. Daiichi Sankyo Business Overview
Table 48. Daiichi Sankyo Myeloid Cells Targeting Therapeutics Product
Table 49. Daiichi Sankyo Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 50. Daiichi Sankyo Recent Development
Table 51. Gilead Sciences Company Detail
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences Myeloid Cells Targeting Therapeutics Product
Table 54. Gilead Sciences Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 55. Gilead Sciences Recent Development
Table 56. Janssen Biotech Company Detail
Table 57. Janssen Biotech Business Overview
Table 58. Janssen Biotech Myeloid Cells Targeting Therapeutics Product
Table 59. Janssen Biotech Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 60. Janssen Biotech Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Myeloid Cells Targeting Therapeutics Product
Table 64. Roche Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Myeloid Cells Targeting Therapeutics Product
Table 69. Pfizer Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. GlaxoSmithKline Company Detail
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Myeloid Cells Targeting Therapeutics Product
Table 74. GlaxoSmithKline Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Macrophage Pharma Company Detail
Table 77. Macrophage Pharma Business Overview
Table 78. Macrophage Pharma Myeloid Cells Targeting Therapeutics Product
Table 79. Macrophage Pharma Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Macrophage Pharma Recent Development
Table 81. Enlivex Company Detail
Table 82. Enlivex Business Overview
Table 83. Enlivex Myeloid Cells Targeting Therapeutics Product
Table 84. Enlivex Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 85. Enlivex Recent Development
Table 86. Immune-Onc Therapeutics Company Detail
Table 87. Immune-Onc Therapeutics Business Overview
Table 88. Immune-Onc Therapeutics Myeloid Cells Targeting Therapeutics Product
Table 89. Immune-Onc Therapeutics Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 90. Immune-Onc Therapeutics Recent Development
Table 91. Infinity Pharmaceuticals Company Detail
Table 92. Infinity Pharmaceuticals Business Overview
Table 93. Infinity Pharmaceuticals Myeloid Cells Targeting TherapeuticsProduct
Table 94. Infinity Pharmaceuticals Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 95. Infinity Pharmaceuticals Recent Development
Table 96. AstraZeneca Company Detail
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Myeloid Cells Targeting TherapeuticsProduct
Table 99. AstraZeneca Revenue in Myeloid Cells Targeting Therapeutics Business (2017-2022) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myeloid Cells Targeting Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Intravenous Injection Features
Figure 3. Oral Features
Figure 4. Global Myeloid Cells Targeting Therapeutics Market Share by Application in 2021 & 2028
Figure 5. Oncological Disorders Case Studies
Figure 6. Rare Disorders Case Studies
Figure 7. Myeloid Cells Targeting Therapeutics Report Years Considered
Figure 8. Global Myeloid Cells Targeting Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Myeloid Cells Targeting Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Myeloid Cells Targeting Therapeutics Market Share by Region: 2021 VS 2028
Figure 11. Global Myeloid Cells Targeting Therapeutics Market Share by Players in 2021
Figure 12. Global Top Myeloid Cells Targeting Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myeloid Cells Targeting Therapeutics as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Myeloid Cells Targeting Therapeutics Revenue in 2021
Figure 14. North America Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Myeloid Cells Targeting Therapeutics Market Share by Country (2017-2028)
Figure 16. United States Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Myeloid Cells Targeting Therapeutics Market Share by Country (2017-2028)
Figure 20. Germany Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Myeloid Cells Targeting Therapeutics Market Share by Region (2017-2028)
Figure 28. China Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Myeloid Cells Targeting Therapeutics Market Share by Country (2017-2028)
Figure 36. Mexico Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Myeloid Cells Targeting Therapeutics Market Share by Country (2017-2028)
Figure 40. Turkey Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Myeloid Cells Targeting Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. ChemoCentryx Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 43. Daiichi Sankyo Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 44. Gilead Sciences Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 45. Janssen Biotech Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 46. Roche Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 47. Pfizer Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 49. Macrophage Pharma Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 50. Enlivex Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 51. Immune-Onc Therapeutics Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 52. Infinity Pharmaceuticals Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 53. AstraZeneca Revenue Growth Rate in Myeloid Cells Targeting Therapeutics Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed